Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm
IF 5.2 2区 医学Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE
{"title":"Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm","authors":"Jing-wen Mu, Ting Cheng, Liang Hu, Biao Lei, Yu-he Ma, Yu Cui, Yan-chun Peng, Wen-bo Huang, You-wen Ge, Ling-Pei Ho, Yue-juan Zheng","doi":"10.1016/j.joim.2026.06.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Post-influenza bacterial infection is associated with higher severity and mortality rates. Qingfei Paidu decoction (QFPDD) has demonstrated efficacy as an anti-inflammatory therapeutic agent specifically for influenza. However, its role in bacterial secondary infection remains unclear. This study aimed to investigate the protective effects and underlying mechanisms of QFPDD in a mouse model of post-influenza bacterial infection.</div></div><div><h3>Methods</h3><div>A mouse model of post-influenza bacterial infection was established to evaluate the therapeutic effects of QFPDD. QFPDD was administered prior to the full establishment of secondary bacterial infection. Body weight, body temperature, lung indexes and pulmonary bacterial load were evaluated by lung weighing and colony counting of lung tissue homogenates. Single-cell ribonucleic acid sequencing (scRNA-seq) was performed to characterize immune cell populations and cytokine expression levels in lung tissues. Neutrophil activation, neutrophil extracellular trap (NET) formation and coagulation-related markers were examined using molecular and biochemical approaches. In vitro, pam<sub>3</sub>cys-ser-lys<sub>4</sub> (Pam3CSK4)-stimulated macrophages were used to assess cytokine production, while the expression of phagocytic receptors was evaluated in macrophages and neutrophils following Pam3CSK4 or heat-killed <em>Staphylococcus aureus</em> stimulation. In addition, phorbol 12-myristate 13-acetate (PMA)-stimulated neutrophils were utilized to assess the production of reactive oxygen species (ROS) and the activation of signaling pathways.</div></div><div><h3>Results</h3><div>QFPDD prevented body weight loss, reduced lung indexes, decreased lung bacterial load and alleviated hypothermia in secondary infected mice. ScRNA-seq analysis revealed decreased cytokine scores in the lungs following QFPDD treatment, with neutrophils exhibiting the highest cytokine scores among the 18 identified cell populations. QFPDD downregulated inflammatory mediators in neutrophils. Furthermore, QFPDD reduced the expression of xanthine oxidase, myeloperoxidase, citrullinated histone H3, and peptidyl arginine deiminase 4, accompanied by decreased S100 calcium-binding protein A8 and S100 calcium-binding protein A9 levels, suggesting that QFPDD can be associated with the reduced formation of NETs. QFPDD also decreased platelet activation and hypercoagulation markers. In vitro, QFPDD inhibited cytokine and chemokine production in macrophages and suppressed ROS generation and extracellular signal-regulated protein kinase phosphorylation in neutrophils. In addition, QFPDD significantly enhanced the expression of phagocytic receptors in macrophages and neutrophils.</div></div><div><h3>Conclusion</h3><div>QFPDD confers protection against post-influenza bacterial infection by inhibiting the formation of NETs and cytokine storm, highlighting its potential as a candidate for further investigation in the prevention and treatment of this condition.</div><div><br>Please cite this article as: Mu JW, Cheng T, Hu L, Lei B, Ma YH, Cui Y, Peng YC, Huang WB, Ge YW, Ho LP, Zheng YJ. Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm. <em>J Integr Med</em>. 2026; 24(5):769–784.</div></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"24 5","pages":"Pages 769-784"},"PeriodicalIF":5.2000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Medicine-Jim","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2095496426000798","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Post-influenza bacterial infection is associated with higher severity and mortality rates. Qingfei Paidu decoction (QFPDD) has demonstrated efficacy as an anti-inflammatory therapeutic agent specifically for influenza. However, its role in bacterial secondary infection remains unclear. This study aimed to investigate the protective effects and underlying mechanisms of QFPDD in a mouse model of post-influenza bacterial infection.
Methods
A mouse model of post-influenza bacterial infection was established to evaluate the therapeutic effects of QFPDD. QFPDD was administered prior to the full establishment of secondary bacterial infection. Body weight, body temperature, lung indexes and pulmonary bacterial load were evaluated by lung weighing and colony counting of lung tissue homogenates. Single-cell ribonucleic acid sequencing (scRNA-seq) was performed to characterize immune cell populations and cytokine expression levels in lung tissues. Neutrophil activation, neutrophil extracellular trap (NET) formation and coagulation-related markers were examined using molecular and biochemical approaches. In vitro, pam3cys-ser-lys4 (Pam3CSK4)-stimulated macrophages were used to assess cytokine production, while the expression of phagocytic receptors was evaluated in macrophages and neutrophils following Pam3CSK4 or heat-killed Staphylococcus aureus stimulation. In addition, phorbol 12-myristate 13-acetate (PMA)-stimulated neutrophils were utilized to assess the production of reactive oxygen species (ROS) and the activation of signaling pathways.
Results
QFPDD prevented body weight loss, reduced lung indexes, decreased lung bacterial load and alleviated hypothermia in secondary infected mice. ScRNA-seq analysis revealed decreased cytokine scores in the lungs following QFPDD treatment, with neutrophils exhibiting the highest cytokine scores among the 18 identified cell populations. QFPDD downregulated inflammatory mediators in neutrophils. Furthermore, QFPDD reduced the expression of xanthine oxidase, myeloperoxidase, citrullinated histone H3, and peptidyl arginine deiminase 4, accompanied by decreased S100 calcium-binding protein A8 and S100 calcium-binding protein A9 levels, suggesting that QFPDD can be associated with the reduced formation of NETs. QFPDD also decreased platelet activation and hypercoagulation markers. In vitro, QFPDD inhibited cytokine and chemokine production in macrophages and suppressed ROS generation and extracellular signal-regulated protein kinase phosphorylation in neutrophils. In addition, QFPDD significantly enhanced the expression of phagocytic receptors in macrophages and neutrophils.
Conclusion
QFPDD confers protection against post-influenza bacterial infection by inhibiting the formation of NETs and cytokine storm, highlighting its potential as a candidate for further investigation in the prevention and treatment of this condition.
Please cite this article as: Mu JW, Cheng T, Hu L, Lei B, Ma YH, Cui Y, Peng YC, Huang WB, Ge YW, Ho LP, Zheng YJ. Qingfei Paidu decoction, a compound Chinese herbal medicine, protects against post-influenza bacterial infection by inhibiting the formation of neutrophil extracellular traps and cytokine storm. J Integr Med. 2026; 24(5):769–784.
期刊介绍:
The predecessor of JIM is the Journal of Chinese Integrative Medicine (Zhong Xi Yi Jie He Xue Bao). With this new, English-language publication, we are committed to make JIM an international platform for publishing high-quality papers on complementary and alternative medicine (CAM) and an open forum in which the different professions and international scholarly communities can exchange views, share research and their clinical experience, discuss CAM education, and confer about issues and problems in our various disciplines and in CAM as a whole in order to promote integrative medicine.
JIM is indexed/abstracted in: MEDLINE/PubMed, ScienceDirect, Emerging Sources Citation Index (ESCI), Scopus, Embase, Chemical Abstracts (CA), CAB Abstracts, EBSCO, WPRIM, JST China, Chinese Science Citation Database (CSCD), and China National Knowledge Infrastructure (CNKI).
JIM Editorial Office uses ThomsonReuters ScholarOne Manuscripts as submitting and review system (submission link: http://mc03.manuscriptcentral.com/jcim-en).
JIM is published bimonthly. Manuscripts submitted to JIM should be written in English. Article types include but are not limited to randomized controlled and pragmatic trials, translational and patient-centered effectiveness outcome studies, case series and reports, clinical trial protocols, preclinical and basic science studies, systematic reviews and meta-analyses, papers on methodology and CAM history or education, conference proceedings, editorials, commentaries, short communications, book reviews, and letters to the editor.
Our purpose is to publish a prestigious international journal for studies in integrative medicine. To achieve this aim, we seek to publish high-quality papers on any aspects of integrative medicine, such as acupuncture and traditional Chinese medicine, Ayurveda medicine, herbal medicine, homeopathy, nutrition, chiropractic, mind-body medicine, taichi, qigong, meditation, and any other modalities of CAM; our commitment to international scope ensures that research and progress from all regions of the world are widely covered. These ensure that articles published in JIM have the maximum exposure to the international scholarly community.
JIM can help its authors let their papers reach the widest possible range of readers, and let all those who share an interest in their research field be concerned with their study.